CVD EQUIPMENT CORP
No enriched coverage for $CVV in the last 7 days.
No SEC Form 4 filings for $CVV in the last 30 days.
See all $CVV insider activity →CVD EQUIPMENT CORP (CVV) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 enabling tomorrow’s technologies™ 355 South Technology Drive, Central Islip, New York 11722 | T 631.981.7081 | F 631.981.7095 | info@cvdequipment.com CVD Equipment Reports Second Quarter 2026 Results; Advances Strategic Transformation Dur
CVD Equipment reported Q4 2025 revenue of $5 million, down 33% year over year and sequentially. Gross margin fell to 22.2% and the company posted a net loss of $1.3 million ($0.18/share). Orders were $3.5 million and backlog $6.6 million. It agreed to sell its SDC segment for $16.9 million cash to Atlas Copco, expected to close in Q2 2026.
CVD Equipment Corporation reported financial results for Q4 and fiscal year 2025, with revenue of $5.0 million and $25.8 million respectively, and net losses for both periods. The company announced the sale of its SDC division to Atlas Copco Group for approximately $16.9 million, expected to close in Q2 2026, to focus on its core CVD Equipment business and enhance financial flexibility. A workforce reduction and updated sales strategy were also implemented to cut operating costs and improve sales.
Recent CVV coverage spans financial news and earnings.
The divestiture materially strengthens liquidity and shifts earnings to a one-time gain, while continuing-ops orders and revenue remain weak.
Earnings show demand deterioration (orders/backlog down) alongside a balance-sheet and cost-reset via SDC divestiture and CVD cost cuts.
CVD Equipment Corporation's sale of its SDC division and Q4/Q5 financial results indicate a strategic shift towards core CVD equipment business, with potential short-term revenue decline but long-term focus on profitable segments.
Despite Q3 earnings showing year-over-year growth, weak bookings and revenues led to a stock decline. Margins improved, but overall sentiment is cautious.
CVV reported weaker second-quarter 2025 results with declines in revenue and earnings; the stock faces near-term downside pressure; long-term growth prospects hinge on new system launches and market adoption.
alphai scores every news story that mentions CVV with an AI model for sentiment and relevance, and aggregates insider trades from CVD EQUIPMENT CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
CVD EQUIPMENT CORP (CVV) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 enabling tomorrow’s technologies™ 355 South Technology Drive, Central Islip, New York 11722 | T 631.981.7081 | F 631.981.7095 | info@cvdequipment.com CVD Equipment Reports Second Quarter 2026 Results; Advances Strategic Transformation Dur
7 min readCVD Equipment reported Q4 2025 revenue of $5 million, down 33% year over year and sequentially. Gross margin fell to 22.2% and the company posted a net loss of $1.3 million ($0.18/share). Orders were $3.5 million and backlog $6.6 million. It agreed to sell its SDC segment for $16.9 million cash to Atlas Copco, expected to close in Q2 2026.
6 min readCVD Equipment Corporation reported financial results for Q4 and fiscal year 2025, with revenue of $5.0 million and $25.8 million respectively, and net losses for both periods. The company announced the sale of its SDC division to Atlas Copco Group for approximately $16.9 million, expected to close in Q2 2026, to focus on its core CVD Equipment business and enhance financial flexibility. A workforce reduction and updated sales strategy were also implemented to cut operating costs and improve sales.
3 min readCVV reports weak bookings and lower third-quarter 2025 revenues, but stronger margins lifted net income on a better contract mix.
2 min readCVV reports weaker second-quarter 2025 results as revenue and earnings decline, while new system launch signals long-term growth focus.
4 min readCVD Equipment posts strong first-quarter 2025 revenue growth and returns to profit, but order slowdown and tariff concerns weigh on stock.
4 min readAbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment are included in this Analyst Blog.
2 min readToday's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), The TJX Companies, Inc. (TJX) and The Charles Schwab Corporation (SCHW), as well as two micro-cap stocks, Enzo Biochem, Inc. (ENZ) and CVD Equipment Corporation (CVV).
5 min read
